Please use this identifier to cite or link to this item:
Title: Health Effects of Resveratrol: Results from Human Intervention Trials
Author: Ramírez-Garza, Sonia L.
Laveriano-Santos, Emily P.
Marhuenda-Muñoz, María
Storniolo, Carolina Emilia
Resserra i Rimbau, Anna
Vallverdú i Queralt, Anna
Lamuela Raventós, Rosa Ma.
Keywords: Biodisponibilitat
Trastorns del metabolisme
Disorders of metabolism
Issue Date: 3-Dec-2018
Publisher: MDPI
Abstract: The effect of resveratrol (RV) intake has been reviewed in several studies performed in humans with different health status. The purpose of this review is to summarize the results of clinical trials of the last decade, in which RV was determined in biological samples such as human plasma, urine, and feces. The topics covered include RV bioavailability, pharmacokinetics, effects on cardiovascular diseases, cognitive diseases, cancer, type 2 diabetes (T2D), oxidative stress, and inflammation states. The overview of the recent research reveals a clear tendency to identify RV in plasma, showing that its supplementation is safe. Furthermore, RV bioavailability depends on several factors such as dose, associated food matrix, or time of ingestion. Notably, enterohepatic recirculation of RV has been observed, and RV is largely excreted in the urine within the first four hours after consumption. Much of the research on RV in the last 10 years has focused on its effects on pathologies related to oxidative stress, inflammatory biomarkers, T2D, cardiovascular diseases, and neurological diseases
Note: Reproducció del document publicat a:
It is part of: Nutrients, 2018, vol. 10, num. 12, p. 1892
Related resource:
ISSN: 2072-6643
Appears in Collections:Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)

Files in This Item:
File Description SizeFormat 
683463.pdf1.15 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons